Korro Bio, Inc. • KRRO

Capital at risk.

About Korro Bio, Inc.
Ticker
info
KRRO
Trading on
info
NASDAQ
ISIN
info
US5009461089
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. Ram Aiyar MBA, Ph.D.
Headquarters
info
60 First Street, Cambridge, MA, United States, 02141
Employees
info
49
Website
info
korrobio.com
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Metrics
BasicAdvanced
Market cap
info
$166M
P/E ratio
info
-
EPS
info
-$11.86
Dividend Yield
info
0.00%
Beta
info
2.21
Forward P/E ratio
info
0
EBIDTA
info
$-79.3M
Ex dividend date
info
-
Price & volume
Market cap
info
$166M
Average daily volume
info
0.2M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
43.17
Price to book
info
1.25
Earnings
EPS
info
-$11.86
EPS estimate (current quarter)
info
-$1.98
EPS estimate (next quarter)
info
-$1.82
EBITDA
info
$-79.3M
Revenues (TTM)
info
$3.8M
Revenues per share (TTM)
info
$0.39
Technicals
Beta
info
2.21
52-week High
info
$55.89
52-week Low
info
$5.20
50-day moving average
info
$12.20
200-day moving average
info
$13.83
Short ratio
info
4.86
Short %
info
11.36%
Management effectiveness
ROE (TTM)
info
-87.78%
ROA (TTM)
info
-26.81%
Profit margin
info
0.00%
Gross profit margin
info
$-44.3M
Operating margin
info
-2,154.03%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
-43.10%
Share stats
Outstanding Shares
info
14.4M
Float
info
9.5M
Insiders %
info
1.00%
Institutions %
info
97.42%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 10 analysts.

Average price target

info
$20.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$2.74
-$2.59
-5.79%
Q2 • 25Missed
-$1.92
-$2.68
28.36%
Q3 • 25Beat
-$1.65
-$2.14
22.90%
Q4 • 25Beat
-$1.69
-$1.98
14.73%
Q1 • 26Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$1.3M
$-50M
-3,873.22%
Q4 • 25
$0M
$-19.6M
-∞%
Q1 • 26
-100.00%
-60.78%
∞%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$114M
$62.1M
54.68%
Q4 • 25
$184M
$64M
34.85%
Q1 • 26
61.77%
3.10%
-36.27%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-17.7M
$15M
$0.4M
$-17.8M
Q4 • 25
$-16.1M
$-32.2M
$88.2M
$-16.1M
Q1 • 26
-9.20%
-314.79%
23,113.68%
-9.51%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Korro Bio, Inc. share?
Collapse

Korro Bio, Inc. shares are currently traded for undefined per share.

How many shares does Korro Bio, Inc. have?
Collapse

Korro Bio, Inc. currently has 14.4M shares.

Does Korro Bio, Inc. pay dividends?
Collapse

No, Korro Bio, Inc. doesn't pay dividends.

What is Korro Bio, Inc. 52 week high?
Collapse

Korro Bio, Inc. 52 week high is $55.89.

What is Korro Bio, Inc. 52 week low?
Collapse

Korro Bio, Inc. 52 week low is $5.20.

What is the 200-day moving average of Korro Bio, Inc.?
Collapse

Korro Bio, Inc. 200-day moving average is $13.83.

Who is Korro Bio, Inc. CEO?
Collapse

The CEO of Korro Bio, Inc. is Dr. Ram Aiyar MBA, Ph.D..

How many employees Korro Bio, Inc. has?
Collapse

Korro Bio, Inc. has 49 employees.

What is the market cap of Korro Bio, Inc.?
Collapse

The market cap of Korro Bio, Inc. is $166M.

What is the P/E of Korro Bio, Inc.?
Collapse

The current P/E of Korro Bio, Inc. is null.

What is the EPS of Korro Bio, Inc.?
Collapse

The EPS of Korro Bio, Inc. is -$11.86.

What is the PEG Ratio of Korro Bio, Inc.?
Collapse

The PEG Ratio of Korro Bio, Inc. is null.

What do analysts say about Korro Bio, Inc.?
Collapse

According to the analysts Korro Bio, Inc. is considered a buy.